Awareness is growing about the importance of invasive and semi-invasive fungal lung disease. Diagnostic methods are still underemphasized, and this may be a factor in the often late recognition of fungal disease. Allergic bronchopulmonary mycoses are important causes of respiratory disease because of their chronic destructive nature. New antifungal agents are needed and must be subject to trial in precisely defined clinical groups.